Louisiana Tech Review
SEE OTHER BRANDS

Hottest science and technology news from Louisiana

Louisiana Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Tech Review.

Press releases published on July 14, 2025

U.S. Crypto Week Heralds Positive Turn — XY Miner Helps XRP and SOL Investors Increase Daily Yields

U.S. Crypto Week Heralds Positive Turn — XY Miner Helps XRP and SOL Investors Increase Daily Yields

London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- The "US Cryptocurrency Week" event held by the U.S. Congress has attracted much attention from global blockchain and digital asset investors. In a series of hearings and legislative proposals, many senators and …

SEALSQ Announces Pricing of $60.0 Million Registered Direct Offering

SEALSQ Announces Pricing of $60.0 Million Registered Direct Offering

Geneva, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- Offering to be led by Heights Capital Management, Inc., and will consist of ordinary shares sold at $4.00 per share, accompanied by warrants with an exercise price of $4.60. SEALSQ Corp (NASDAQ: LAES) …

Enovix Appoints Srikanth Kethu as Head of Enovix India to Accelerate Global Innovation and Regional Expansion

Enovix Appoints Srikanth Kethu as Head of Enovix India to Accelerate Global Innovation and Regional Expansion

FREMONT, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a leader in advanced silicon battery technology, today announced the appointment of Srikanth Kethu as Head of Enovix India, effective today. In this key …

Impact Analytics Partners with KiK to Deliver AI-Optimized Planning, Merchandising, Inventory Management and More

Impact Analytics Partners with KiK to Deliver AI-Optimized Planning, Merchandising, Inventory Management and More

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Impact Analytics, the leader in AI-native planning, merchandising, inventory and pricing solutions for the retail, grocery, manufacturing and CPG industries, is proud to announce its partnership with German …

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey …

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in  Familial Adenomatous Polyposis (FAP)

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …

CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors

CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors

SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of two new members to its Board of Directors (“Board”). Effective …

Disc Medicine Appoints Nadim Ahmed to its Board of Directors

Disc Medicine Appoints Nadim Ahmed to its Board of Directors

WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …

Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform

Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform

Washington, D.C, July 14, 2025 (GLOBE NEWSWIRE) -- As Bitcoin surged over 300% between 2020 and 2023, digital assets have moved from speculative bets to a central pillar of modern finance. Billionaires like Elon Musk and Michael Saylor, and institutions …

Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3

Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3

TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …

Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners

Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners

London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer

--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …

MKS Inc. Announces Second Quarter 2025 Earnings Conference Call

MKS Inc. Announces Second Quarter 2025 Earnings Conference Call

ANDOVER, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2025 financial results after market close on …

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)

IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …

LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership

LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time

DALLAS, July 14, 2025 (GLOBE NEWSWIRE) --  Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …

Rumble Names Ian O’Donnell VP for Rumble Cloud

Rumble Names Ian O’Donnell VP for Rumble Cloud

LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions